LakeShore Biopharma
LSB • XNAS
LakeShore Biopharma is a publicly traded company on XNAS, with a market cap of $25.8M. As of Q3 2025, 0% of shares are held by 1 institutional investors, with BARCLAYS PLC as the largest holder at -.
Overview
Overview of institutional ownership in LSB as of Q3 2025 with a market cap of $25.8M
All Institutions
- Institutions
- 1
- Value Held
- $18.1K
- Shares Held
- 24.8K
- Avg Position
- $18.1K
- Median Position
- $18.1K
Hedge Funds
- Hedge Funds
- 0
- Value Held
- -
- Shares Held
- -
- Avg Position
- -
- Median Position
- -
Ownership Breakdown
Based on market cap of $25.8M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Biggest Investors
Institutions with the largest positions in LSB as of Q3 2025
| Institution | Position Value |
|---|---|
 BARCLAYS PLC Institution | $18.1K 0.00% of portfolio |
 UBS Group AG Institution | - 0.00% of portfolio |
 ORBIMED ADVISORS LLC Hedge Fund•Sector | - 0.00% of portfolio |
H Hillhouse Capital Advisors, Ltd. Institution | - 0.00% of portfolio |
 FMR LLC Institution | - 0.00% of portfolio |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | - 0.00% of portfolio |
 CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | - 0.00% of portfolio |
Net Capital Flow
Institutional buying and selling activity for LSB in Q3 2025
- Traded
- −$304.7K
- Buyers
- 0
- Sellers
- 6
- Total Bought
- +-
- Total Sold
- −$304.7K
- Avg Position
- $2.6K
Biggest Buyers
| Institution | Net Bought | |
|---|---|---|
| No buyers found | ||
Biggest Sellers
| Institution | Net Sold |
|---|---|
FMR LLC Institution | −$118.8K −116.5K shares |
H Hillhouse Capital Advisors, Ltd. Institution | −$76.7K −75.2K shares |
ORBIMED ADVISORS LLC Hedge Fund•Sector | −$55.9K −54.8K shares |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | −$31.4K −30.8K shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | −$15.3K −15.0K shares |
UBS Group AG Institution | −$6.6K −6.5K shares |
Entry and Exit Activity
Institutions that initiated new positions or completely exited LSB in Q3 2025
- New Positions
- 0
- New Value
- -
- Exited Positions
- 6
- Exited Value
- $304.7K
New Positions
| Institution | Position Value |
|---|---|
| No new positions found | |
Exited Positions
| Institution | Previous Position |
|---|---|
FMR LLC Institution | $118.8K 116.5K shares |
H Hillhouse Capital Advisors, Ltd. Institution | $76.7K 75.2K shares |
ORBIMED ADVISORS LLC Hedge Fund•Sector | $55.9K 54.8K shares |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | $31.4K 30.8K shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $15.3K 15.0K shares |
UBS Group AG Institution | $6.6K 6.5K shares |
Options Activity
Institutions with the largest Call and Put options positions in LSB as of Q3 2025
- Call Positions
- 0
- Call Value
- -
- Put Positions
- 0
- Put Value
- -
Call Positions
| Institution | Position Value |
|---|---|
| No call positions found | |
Put Positions
| Institution | Position Value |
|---|---|
| No put positions found | |
Most Committed Institutions
Institutions with LSB as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
BARCLAYS PLC Institution | 0.00% $18.1K |
UBS Group AG Institution | 0.00% - |
ORBIMED ADVISORS LLC Hedge Fund•Sector | 0.00% - |
H Hillhouse Capital Advisors, Ltd. Institution | 0.00% - |
FMR LLC Institution | 0.00% - |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | 0.00% - |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | 0.00% - |